Reliable machines are the backbone of every OSD production. To ensure they remain so, they require process expertise from the very first stage of development.
Key Takeaways
- Dr. Barbara Fretter takes over as Head of Pharma Process Services Solid in Fellbach
- Pharma Process Services Solid now has an even broader scope
- Services from R&D through the end of the product lifecycle – for greater efficiency, shorter time-to-market, and higher OEE
Syntegon’s Pharma Process Expert Services Solid support pharmaceutical and nutraceutical manufacturers from the initial development stage through the entire product lifecycle. This understanding of co-creation shapes the work of our interdisciplinary team of experts and global network of customer centers and laboratories. In addition to our process and equipment expertise, we support customers as early as the initial R&D phases – where their own teams reach limits in capacity or knowledge and external support makes all the difference. Because the sooner manufacturers align formulation and production processes, the lower the risks during large-scale production. Together, we shorten your time-to-market and increase your product yield – whether it’s powder, pellets, granules, tablets, or capsules.
In-depth expertise for your OSD pharmaceuticals and nutraceuticals
To further develop this know-how and support you even more effectively in optimizing your OSD processes, we have brought on Dr. Barbara Fretter as an industry expert. At the beginning of the year, she took over as the new Head of Pharma Process Services Solid at the Fellbach site, succeeding Dr. Thomas Brinz, who has since joined the newly established Business Development department.
Barbara draws on many years of experience in industrial research, development, and process consulting. As co-founder and managing director of Solids Development Consult GmbH, she has supported numerous pharmaceutical, nutraceutical, and chemical companies in the development of reliably processable OSD formulations and their transition to production. She is now bringing this practical knowledge to Syntegon – and combining it with our clients’ expertise:
“Many companies have excellent knowledge of their products, but not always the capacity or the external perspective to deeply understand processes. This is exactly the gap we want to close – as a partner with foresight, co-developing and sharing responsibility.”
Dr. Barbara Fretter, Head of Pharma Process Services Solid in Fellbach
Partnership across the entire OSD lifecycle
“For us, feasibility studies are not a standalone offering, but the starting point for a long-term collaboration. They help us truly understand our customers’ process environment and make us even better at supporting active ingredients from development, through formulation, market launch, and scale-up all the way to production, as well as consulting on compliance issues,” Barbara continues. “Combined with our detailed knowledge of our own machines, this gives pharmaceutical and nutraceutical companies access to an in-depth process expertise that is difficult to build internally – and a partner who further develops this knowledge together with them.”
With comprehensive consulting and its OSD machine portfolio, Syntegon covers the technical foundation of production. The service portfolio encompasses all stages from commissioning through preventive maintenance and digital tools to line upgrades and technical transfers. We combine our customers’ production knowledge with our equipment expertise to reduce unplanned downtime, improve processes, and ensure the best product quality in the long term. This fosters a partnership that spans the entire product lifecycle and lays the foundation for sustainable growth.
Syntegon Newsletter
Get inspired with regular updates on technologies and services, case studies, webinar offers and events.